2010 Arab Health Exhibition and Congress Set to Open
|
By LabMedica International staff writers Posted on 18 Jan 2010 |
The 2010 edition of the Arab Health Exhibition and Congress (Dubai, UAE), the largest healthcare exhibition in the Middle East and the second largest in the world, will be larger and improved over those of the previous years.
Established 35 years ago, the Arab Health Exhibition and Congress provides a platform for leading manufacturers, wholesalers, and distributors to meet the medical and scientific community in the Middle East and beyond. Arab Health 2010 will feature more than 2,500 exhibitors from over 65 countries, including 30 national pavilions and two specialized zones for medical laboratory products and international health services; four additional halls added to the Dubai International Convention & Exhibition Center (UAE) will enlarge the exhibition to an area covering over 85,000 square meters. An estimated 55,000 medical professionals, distributors, dealers and suppliers from 145 countries are expected to attend the 2010 edition, which will be held on January 25-28, 2010.
The exhibition covers a wide range of medical sectors, including medical technology, laboratory equipment, diagnostics, physiotherapy and orthopedic technology, commodities and consumer goods for hospitals; information and communication technology in healthcare services; surgical products and services, facility management services, medical disposables, healthcare building technology, medical services, radiology, imaging and diagnostics, and other fields.
"Last year we hit capacity and were unable to accommodate all potential exhibitors in the space available at the Dubai International Exhibition and Convention Center,” said Simon Page, director of the life science division of IIR Middle East (Dubai,UAE), the organizers of the Arab Health Exhibition and Congress. "But with the opening of new facilities providing a further 20,000 square meters of hall space, we are expecting Arab Health to grow by over 20% as the region continues to develop a modern healthcare system.”
Dubai International Exhibition Center is centrally located in the heart of Dubai's business district, only 20 minutes from Dubai International Airport. The venue has all the facilities an international exhibition center including meeting points, VIP lounges, Internet and business center facilities, hotels, and restaurants.
Related Links:
Arab Health Exhibition & Congress
Dubai International Convention & Exhibition Center
IIR Middle East
Established 35 years ago, the Arab Health Exhibition and Congress provides a platform for leading manufacturers, wholesalers, and distributors to meet the medical and scientific community in the Middle East and beyond. Arab Health 2010 will feature more than 2,500 exhibitors from over 65 countries, including 30 national pavilions and two specialized zones for medical laboratory products and international health services; four additional halls added to the Dubai International Convention & Exhibition Center (UAE) will enlarge the exhibition to an area covering over 85,000 square meters. An estimated 55,000 medical professionals, distributors, dealers and suppliers from 145 countries are expected to attend the 2010 edition, which will be held on January 25-28, 2010.
The exhibition covers a wide range of medical sectors, including medical technology, laboratory equipment, diagnostics, physiotherapy and orthopedic technology, commodities and consumer goods for hospitals; information and communication technology in healthcare services; surgical products and services, facility management services, medical disposables, healthcare building technology, medical services, radiology, imaging and diagnostics, and other fields.
"Last year we hit capacity and were unable to accommodate all potential exhibitors in the space available at the Dubai International Exhibition and Convention Center,” said Simon Page, director of the life science division of IIR Middle East (Dubai,UAE), the organizers of the Arab Health Exhibition and Congress. "But with the opening of new facilities providing a further 20,000 square meters of hall space, we are expecting Arab Health to grow by over 20% as the region continues to develop a modern healthcare system.”
Dubai International Exhibition Center is centrally located in the heart of Dubai's business district, only 20 minutes from Dubai International Airport. The venue has all the facilities an international exhibition center including meeting points, VIP lounges, Internet and business center facilities, hotels, and restaurants.
Related Links:
Arab Health Exhibition & Congress
Dubai International Convention & Exhibition Center
IIR Middle East
Latest Industry News
- Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
- Diazyme Laboratories Acquires Carolina Liquid Chemistries
- Partnership Expands Access to Alzheimer’s Blood Tests in Latin America and Caribbean
- Global Multiplex Assays Market Driven by High-Throughput Diagnostic Demand
- GRAIL Presents Full Results from NHS-Galleri Trial at ASCO 2026
- Global Framework Integrates Digital Pathology for Companion Diagnostic Development
- Werfen and Oxford Nanopore Collaborate on Transplant Assay Development
- New Distribution Agreement Expands Access to CE-Marked Precision Oncology Assays
- ClearNote Health to Present Pancreatic Cancer Blood Test Data at ASCO 2026
- Artera to Highlight AI-Based Cancer Risk Stratification at ASCO 2026
- Natera to Present Data on MRD-Guided Cancer Care at ASCO 2026
- Fujifilm Integrates Structured Reporting into Digital Pathology Workflow
- Strategic Collaboration Advances RNA Foundation Models for Precision Oncology
- Partnership Brings Single-Cell Analysis into Clinical Oncology Workflows
- Partnership Aims to Bring Risk-Guided CKD Care to Health Systems
- AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








